Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma ...Middle East

HEPZATO KIT is the only FDA approved liver-directed therapy to treat metastatic uveal melanoma Approval includes treatment naïve and previously treated patients and is not limited by HLA genotype Delcath to hold Business Update Call on August 15, 2023 at 8:00 a.m. Eastern Time NEW YORK,...

Hence then, the article about delcath systems inc announces fda approval of hepzato kit for the treatment of adult patients with unresectable hepatic dominant metastatic uveal melanoma was published today ( Tuesday 15/08/2023 - 04:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma )

Also on site :

• In wild late-night posting spree, Trump attacks Obama with imaginary quote and false conspiracy theories
• WNBA Star Announced as Cover Model for Vanity Fair's First-Ever Global Sports Issue
• Dylan Dreyer Reveals Surprising Celebrity Relative